Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisMattía Galli, Dominick J. Angiolillo, Stefano Benenati et al.|The Lancet|2021Cited by 229
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trialsMattía Galli, Dominick J. Angiolillo, Larisa H. Cavallari et al.|European Heart Journal|2021Cited by 150
Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarctionMattía Galli, Filippo Crea, Giampaolo Niccoli et al.|Nature Reviews Cardiology|2023Cited by 139
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients With Recurrent Acute Coronary Syndromes Compared With Patients With Long-term Clinical StabilityRocco Vergallo, Filippo Crea, Italo Porto et al.|JAMA Cardiology|2019Cited by 125
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trialsStefano Benenati, Mattía Galli, Vincenzo De Marzo et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2020Cited by 56